HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of 'locked-in' antibiotic to treat an unusual gram-negative hemodialysis catheter infection.

Abstract
A 37-year-old woman on maintenance hemodialysis for 3 years had multiple vascular access failures due to antiphospholipid syndrome. She was dialyzed via a tunneled left subclavian catheter, but after 1 year developed chills and fever during each dialysis session. Blood cultures grew out Xanthomonas maltophilia sensitive to ceftazidime and ciprofloxacin. Intravenous administration of both antibiotics failed to eradicate infection. We added 'locked-in' ceftazidime, instilling it daily into the catheter along with heparinized saline for 3 weeks. Within 24 h the patient was dialyzed uneventfully, and all subsequent blood cultures have been negative. This case shows the successful use of a 'locked-in' antibiotic to treat an unusual gram-negative catheter infection. Two prior series have reported similar good results in infections with more common organisms. Such treatment may permit continued use of tunneled hemodialysis catheters for longer periods.
AuthorsJ Shah, D A Feinfeld
JournalNephron (Nephron) Vol. 85 Issue 4 Pg. 348-50 (Aug 2000) ISSN: 1660-8151 [Print] Switzerland
PMID10940747 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2000 S. Karger AG, Basel
Chemical References
  • Cephalosporins
  • Ceftazidime
Topics
  • Adult
  • Catheters, Indwelling (microbiology)
  • Ceftazidime (administration & dosage)
  • Cephalosporins (administration & dosage)
  • Female
  • Gram-Negative Bacterial Infections (drug therapy)
  • Humans
  • Injections, Intravenous
  • Kidney Failure, Chronic (microbiology, therapy)
  • Renal Dialysis
  • Stenotrophomonas maltophilia

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: